cas 5342-23-4|| where to buy 6-methoxy-4-methylquinolin-2(1H)-one

Nombre del producto:6-methoxy-4-methylquinolin-2(1H)-one

IUPAC Name:6-methoxy-4-methyl-1,2-dihydroquinolin-2-one

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM143907-1g	in stock	ǪƈŹ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 5342-23-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :5342-23-4; Fórmula molecular:C11H11NO2; Punto de fusión:-; Código de sonrisas:O=C1NC2=C(C=C(OC)C=C2)C(C)=C1; Densidad:

: Número de catálogo:CM143907; Peso molecular:189.21; Punto de ebullición:391.6°C at 760 mmHg; Nº Mdl:MFCD00760266; Almacenamiento:Store at 2-8°C.

: Quinolines; Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.; Quinoline Price; if you have any question on quinoline price, we will give the professional answers to your short questions.

: Tafenoquine; 60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.

Product Overview	6-Methoxy-4-methylquinolin-2(1H)-one (5342-23-4) is a synthetic compound that has been extensively studied for its potential use in various scientific research applications. 6-Methoxy-4-methylquinolin-2(1H)-one is a quinoline derivative that has been shown to have promising properties in terms of its mechanism of action, biochemical and physiological effects, and advantages and limitations for laboratory experiments.
Physical Properties	Appearance: 6-Methoxy-4-methylquinolin-2(1H)-one (5342-23-4) is a off-white powder solid. Melting Point: When in solid form, it typically has a melting point of around 270 °C.
Synthesis and Application	6-Methoxy-4-methylquinolin-2(1H)-one has been studied for its potential use in a variety of scientific research applications, including as an antioxidant, anti-inflammatory, and anti-cancer agent. It has also been investigated for its potential use in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
Storage and Handling	Store 6-Methoxy-4-methylquinolin-2(1H)-one at 2-8°C.